Skip to content
healthcare.dev

Hydralazine Hydrochloride

NDC 23155-835, Hydralazine Hydrochloride, tablet, from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc..

Product NDC
23155-835
Status
Listed
Labeler
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA040858
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/23155-835 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDRALAZINE HYDROCHLORIDE100 mg/1

Pharmacologic classes

Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]

Package NDCNDC-11Package
23155-835-0123155083501100 TABLET in 1 BOTTLE (23155-835-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/669532c9-ba15-4f4b-95a8-13782deb3521
  • NADAC price for package 23155083501

    GET /v1/drugs/nadac/23155083501

Use it

Look up 23155-835 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/23155-835 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 23155-835. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.